About Niowave
Niowave is a company based in United States founded in 2006. Niowave has raised $9.95 million across 21 funding rounds from investors including SBIR and OSTI.GOV. Niowave operates in a competitive market with competitors including ARTMS, NorthStar Medical Radioisotopes, Mercurius Health, Mediso and Nanovista, among others.
- Headquarter United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$9.95 M (USD)
in 21 rounds
-
Latest Funding Round
$1.95 M (USD), Series A
Dec 14, 2021
-
Investors
SBIR
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Niowave
Unlock access to complete
Unlock access to complete
Funding Insights of Niowave
Niowave has successfully raised a total of $9.95M across 21 strategic funding rounds. The most recent funding activity was a Series A round of $1.95 million completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Niowave
Niowave has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include SBIR and OSTI.GOV.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Federal innovation and scientific achievement services are provided.
|
Locked | Locked | Locked | |
|
Scientific and technical information is managed and disseminated by OSTI.GOV.
|
Locked | Locked | Locked |
Investor details for Niowave
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Niowave
Investment portfolio details for Niowave
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Niowave
Detailed financials for Niowave
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Niowave Comparisons
Peer comparison for Niowave
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Niowave
Niowave operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ARTMS, NorthStar Medical Radioisotopes, Mercurius Health, Mediso and Nanovista, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Radioisotope technologies and services are developed and provided by ARTMS.
|
|
| Locked | Locked | Locked |
Provider of sourcing, purification, and separation technologies for the Nuclear Medicine market
|
|
| Locked | Locked | Locked |
Resources and training for radiotherapy and nuclear medicine are provided.
|
|
| Locked | Locked | Locked |
Nuclear medicine and hybrid imaging equipment
|
|
| Locked | Locked | Locked |
Multimodal visualization agents are developed for image-guided interventions.
|
Detailed competitors of Niowave
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Niowave
Complete news archive for Niowave
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Niowave
Niowave was founded in 2006 and raised its 1st funding round 1 year after it was founded.
Niowave is headquartered in United States.
Mike Zamiara is the current CEO of Niowave.
Niowave is a funded company, having raised a total of $9.95M across 21 funding rounds to date.
Niowave was founded in 2006 in the United States and operates within the medical diagnostics and research sector. Superconducting electron linear accelerators, medical radioisotopes, high-power X-ray sources, and high-flux neutron sources are produced by the company. These products support nuclear imaging applications and related research activities across the industry.
Niowave's top competitors include ARTMS, NorthStar Medical Radioisotopes and ATOMIC ALCHEMY.